Get in touch

Tiefenbacher Group, OnDosis and Star celebrate iF Design Award for OYSTA

Tiefenbacher Group - A digital display showcases Oysta, a patient management tool focused on patient-centric drug development, on a tablet and smartphone. The Tiefenbacher Group and IF Design Award logos highlight ONDOSIS & STAR's award-winning design for Oysta.

We are proud to announce that OYSTA has been honored with the prestigious iF Design Award for its excellence in digital innovation and user-centric design.This award is a testament to our shared vision and collaborative efforts of our partners—global life science company OnDosis AB and global technology consultancy Star—to redefine medication management for ADHD and […]

OYSTA receives UX Design Award 2024

Tiefenbacher Group - A group of thirteen people in business attire stand smiling together outside a historic Gothic-style building, representing leaders in pharmaceutical healthcare solutions and patient-centric drug development.

We are happy to announce that our beloved OYSTA project has been awarded with the prestigious UX Design Award.Thanks to the outstanding work of our partner Star, a global technology consultancy, which takes care of OYSTA Digital Service, the companion to our OYSTA Dosage Manager. In recognition of the exceptional design and innovation behind the […]

Tiefenbacher Group raises awareness of autism

Tiefenbacher Group - A group of thirteen people in business attire stand smiling together outside a historic Gothic-style building, representing leaders in pharmaceutical healthcare solutions and patient-centric drug development.

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Tiefenbacher Group raises awareness of autism on today’s World Autism Awareness Day.The aim of World Autism Awareness Day is to draw attention to the needs and lifelong struggles of autistic people worldwide. It was founded on 2 April 2007 by the United Nations General Assembly. This year is being held across Europe under the motto […]

New agreement expands collaboration between OnDosis and TIEFENBACHER GROUP

Tiefenbacher Group - Two white and teal handheld medical devices with digital displays showing “10 mg,” next to the Tiefenbacher Group and Ondosis logos, highlight advanced pharmaceutical healthcare solutions for finished dosage forms on a white background.

Innovative Healthcare Pharmaceuticals with e-health technology in the ADHD field, rare diseases, and transplantation medicineSwedish Life science company OnDosis and German B2B pharmaceutical company TIEFENBACHER GROUP initiate four new innovative development projects targeting ADHD, rare diseases, and transplantation medicine. The idea is to improve the health and everyday lives of millions of patients by giving […]

Tiefenbacher Group and OnDosis enter a partnership for medicines and digital health

Tiefenbacher Group - Logos of Tiefenbacher Group (blue dots and text) and Ondosis (green and maroon text with a capsule icon) on a white background, representing leaders in patient-centric drug development and pharmaceutical healthcare solutions.

Tiefenbacher Group and OnDosis today announced the signing of an extensive co-development agreement for multiple products in the upcoming years. This collaboration strengthens both companies’ commitment to further develop and commercialize innovative products within individualized treatments and digital health, combining traditional drug-based medicines with digital therapeutics and intelligent dosing. TIEFENBACHER GROUP and OnDosis enter a […]

Get in touch